Clinical Trial Update: A Study of Niraparib in Patients With Relapsed Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating niraparib in relapsed ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Zai Lab (Shanghai) Co., Ltd. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED